Search found 10 matches

by johnrob
Fri Mar 03, 2006 9:01 am
Forum: General Discussion
Topic: Who owns this site?
Replies: 15
Views: 5440

Re: Who owns this site?

Begs the question who profits from this site? IF profit is involved - maybe the site is not as "unbiased" as one would think. hmmm... Well Johnrob.....you certainly think highly enough of this site to copy a message from it and paste it on another MS Forum :wink: Harry huh? The only other...
by johnrob
Thu Mar 02, 2006 5:08 pm
Forum: General Discussion
Topic: Who owns this site?
Replies: 15
Views: 5440

Well said and much appreciated....

Well said and much appreciated.... Maybe you "whomever you are" should consider going non-profit... Give your site some added legitimacy. Just a thought... Turn your 2500 members into 25,000 or more. Considering some 400,000 thousand of us are MS'ers in the USA alone. Plagerized below beca...
by johnrob
Thu Mar 02, 2006 12:47 pm
Forum: Tysabri (Antegren, Natalizumab)
Topic: EMail to FDA/AC ie TEVA
Replies: 14
Views: 4690

John, In the mean time this so called "unbiased MS community" site is making up stats to scare people. As stated on the main page "1-1000 chance of contracting PML" - what scientist/expert came up with that number??? Maybe this site is funded by TEVA? Please see: http://content....
by johnrob
Thu Mar 02, 2006 11:37 am
Forum: Tysabri (Antegren, Natalizumab)
Topic: EMail to FDA/AC ie TEVA
Replies: 14
Views: 4690

Johrob, anything out of the original context is dangerous and biased if you ask me.... Maybe the scientist(s) who discovered the monocloal antibodies way back in the 70's were in on the big $ conspiracy. If that is the case then everyone here or on any other MS Forum should just copy and paste arti...
by johnrob
Thu Mar 02, 2006 7:29 am
Forum: Tysabri (Antegren, Natalizumab)
Topic: EMail to FDA/AC ie TEVA
Replies: 14
Views: 4690

Johnrob, In the mean time this so called "unbiased MS community" site is making up stats to scare people. As stated on the main page "1-1000 chance of contracting PML" - what scientist/expert came up with that number??? Maybe this site is funded by TEVA? This site hasn't been &q...
by johnrob
Thu Mar 02, 2006 7:11 am
Forum: General Discussion
Topic: Who owns this site?
Replies: 15
Views: 5440

Who owns this site?

Begs the question who profits from this site? IF profit is involved - maybe the site is not as "unbiased" as one would think. hmmm... Just out of curosity : Do a whois search on the domain name "thisisms.com" then do a search on the phone number listed (480) 624-2599 I did... You...
by johnrob
Thu Mar 02, 2006 6:13 am
Forum: Tysabri (Antegren, Natalizumab)
Topic: EMail to FDA/AC ie TEVA
Replies: 14
Views: 4690

hmm, but the Teva fear mongering isn't much different than that on this board. :P Except that Teva is using "scientists" to state their concerns!! Kind of makes you wonder whether potential revenue outweighs scientific accuracy when Tysabari is involved. Then are we supposed to believe wh...
by johnrob
Thu Mar 02, 2006 3:57 am
Forum: Tysabri (Antegren, Natalizumab)
Topic: TYSABRI® Two-Year Phase III Published in New England Journal
Replies: 4
Views: 4720

"The incidence of serious adverse events was not significantly different between the two treatment groups in each trial, and in each trial the most common serious adverse event was MS relapse." I suffer from debilitating fatigue without ANY meds... I just want to slow progression. The curr...
by johnrob
Wed Mar 01, 2006 5:17 pm
Forum: Tysabri (Antegren, Natalizumab)
Topic: TYSABRI® Two-Year Phase III Published in New England Journal
Replies: 4
Views: 4720

TYSABRI® Two-Year Phase III Published in New England Journal

http://www.elan.com/news/print_full.asp?ID=824216 1 March 2006 TYSABRI® Two-Year Phase III Multiple Sclerosis Clinical Trial Results and Safety Evaluation Published in New England Journal of Medicine; TYSABRI Currently Under Review with U.S. and European Regulatory Authorities CAMBRIDGE, Mass. and D...
by johnrob
Wed Feb 15, 2006 11:47 am
Forum: Tysabri (Antegren, Natalizumab)
Topic: TYSABRI(R) Resume Clinical Trial Dosing in MS
Replies: 9
Views: 4486

TYSABRI(R) Resume Clinical Trial Dosing in MS

http://www.elan.com/News/full.asp?ID=817575 TYSABRI® Multiple Sclerosis Clinical Trial Hold Lifted by FDA; Biogen Idec and Elan to Resume Clinical Trial Dosing in MS CAMBRIDGE, Mass. and DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 15, 2006--Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc. (NYSE: ELN...

Go to advanced search